These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

60 related articles for article (PubMed ID: 9798612)

  • 1. Antenatal screening for Down's syndrome.
    Madhok R
    Lancet; 1998 Oct; 352(9134):1145. PubMed ID: 9798612
    [No Abstract]   [Full Text] [Related]  

  • 2. Antenatal screening policies for Down's syndrome. Audit of Down's syndrome screening is not valid.
    Wald NJ; Huttly W; Hackshaw AK
    BMJ; 2002 Nov; 325(7371):1034; author reply 1034. PubMed ID: 12411371
    [No Abstract]   [Full Text] [Related]  

  • 3. Antenatal screening for Down's syndrome.
    Statham H; Solomou W
    Lancet; 1998 Dec; 352(9143):1862. PubMed ID: 9851420
    [No Abstract]   [Full Text] [Related]  

  • 4. Antenatal screening for Down's syndrome.
    Venn-Treloar JM
    Lancet; 1998 Oct; 352(9134):1145. PubMed ID: 9798613
    [No Abstract]   [Full Text] [Related]  

  • 5. Ethnic differences in informed decision-making about prenatal screening for Down's syndrome.
    Fransen MP; Essink-Bot ML; Vogel I; Mackenbach JP; Steegers EA; Wildschut HI
    J Epidemiol Community Health; 2010 Mar; 64(3):262-8. PubMed ID: 19692718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antenatal screening for Down's syndrome.
    Williams ES
    BMJ; 1992 Sep; 305(6856):769-70; author reply 771. PubMed ID: 1422341
    [No Abstract]   [Full Text] [Related]  

  • 7. Antenatal screening for Down's syndrome with the quadruple test.
    Wald NJ; Huttly WJ; Hackshaw AK
    Lancet; 2003 Mar; 361(9360):835-6. PubMed ID: 12642052
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antenatal screening policies for Down's syndrome. Serum screening for Down's syndrome is better than age screening.
    Christiansen M; Larsen SO; Nørgaard-Pedersen B
    BMJ; 2002 Nov; 325(7371):1034; author reply 1034. PubMed ID: 12420332
    [No Abstract]   [Full Text] [Related]  

  • 9. The ethics of using modern technology for detecting Down's syndrome.
    Churchman J
    Radiogr Today; 1989 Jul; 55(626):25. PubMed ID: 2531595
    [No Abstract]   [Full Text] [Related]  

  • 10. Estimating the risk of Down's syndrome in antenatal screening and the gestation at which this risk applies.
    Morris JK; Wald NJ
    J Med Screen; 2007; 14(1):5-7. PubMed ID: 17362564
    [TBL] [Abstract][Full Text] [Related]  

  • 11. From policy making to service use. Down's syndrome antenatal screening in England, France and the Netherlands.
    Vassy C; Rosman S; Rousseau B
    Soc Sci Med; 2014 Apr; 106():67-74. PubMed ID: 24534734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum screening for Down's syndrome. Informed consent is vital..
    Waldron G; Williams ES
    BMJ; 1993 Aug; 307(6902):500-1. PubMed ID: 8400944
    [No Abstract]   [Full Text] [Related]  

  • 13. The future of prenatal diagnosis: rapid testing or full karyotype? An audit of chromosome abnormalities and pregnancy outcomes for women referred for Down's Syndrome testing.
    Ogilvie CM; Lashwood A; Chitty L; Waters JJ; Scriven PN; Flinter F
    BJOG; 2005 Oct; 112(10):1369-75. PubMed ID: 16167939
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down's syndrome: screening and antenatal diagnosis regionally in England and Wales 1989-2008.
    De Souza E; Alberman E; Morris JK
    J Med Screen; 2010; 17(4):170-5. PubMed ID: 21258126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fetuses with Down's Syndrome detected by prenatal screening are more likely to abort spontaneously than fetuses with Down's Syndrome not detected by prenatal screening.
    Leporrier N; Herrou M; Morello R; Leymarie P
    BJOG; 2003 Jan; 110(1):18-21. PubMed ID: 12504930
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The future of antenatal screening for Down's Syndrome.
    Alfirevic Z
    BJOG; 2005 Jan; 112(1):128; author reply 128. PubMed ID: 15663419
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical implications of the ethics of informed consent for first-trimester risk assessment for trisomy 21.
    Chervenak FA; McCullough LB; Chasen ST
    Semin Perinatol; 2005 Aug; 29(4):277-9. PubMed ID: 16104682
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Do pregnant women in Greece make informed choices about antenatal screening for Down's syndrome? A questionnaire survey.
    Gourounti K; Sandall J
    Midwifery; 2008 Jun; 24(2):153-62. PubMed ID: 17316936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Ethical aspects of prenatal screening for Down's syndrome].
    Tóth A; Szabó J
    Orv Hetil; 2000 Oct; 141(42):2293-8. PubMed ID: 11076495
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prenatal biochemical screening for Down's syndrome and neural tube defects.
    Wald NJ; Kennard A
    Curr Opin Obstet Gynecol; 1992 Apr; 4(2):302-7. PubMed ID: 1373963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.